Navenio secures £400,000 UKRI grant funding to ease COVID-19 impact on healthcare
The grant has been awarded to Navenio’s ‘Intelligent Workforce Solution’, to mitigate the impact of COVID-19 on healthcare systems Navenio’s...
Staff
Aptevo Therapeutics Announces Second Complete Remission in Ongoing APVO436 Phase 1 Clinical Trial
Second Complete Remission Observed in a Patient in Cohort 6 Enrollment in Cohort 8 Has Started SEATLLE, WA / ACCESSWIRE...
Colorado Springs Based Industrial Hemp Farms Lowers Prices On Their CBD Oil
IHF Online offers its CBD Oil at the best price in the industry. A review of prices across the industry...
Aptevo Therapeutics Adopts Limited Duration Stockholder Rights Plan
SEATTLE, WA / ACCESSWIRE / November 8, 2020 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a biotechnology company focused on developing...
Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon
Philips Stellarex low-dose drug-coated balloon November 07, 2020 Meta-analysis of two major randomized controlled trials (RCTs) show no difference in...
Shockwave IVL Is Superior to Angioplasty in Severely Calcified Peripheral Artery Disease
Disrupt PAD III is Largest Randomized Study of Complex Patients Typically Excluded from Clinical Trials SANTA CLARA, Calif., Nov. 07,...
Inari Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
IRVINE, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) announced today that its management team...
Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease
CAMBRIDGE, Mass. and TOKYO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Today, the U.S. Food and Drug Administration (FDA) Peripheral and...
Braingrid Limited Announces Share Consolidation
TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”), is pleased to announce that...
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights
HOPKINTON, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company...
Golden Leaf Holdings Announces Resignation of President Stanley Grissinger
CEO Jeff Yapp to assume role of President TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE:GLH)...
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing...
Obalon Announces Third Quarter 2020 Financial Results
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the...
Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority) NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Listing...
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to two new...
Mustang Bio Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
WORCESTER, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
Premier Health Completes the Previously Announced Acquisition of Code Bleu
MONTRÉAL, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (formerly known as Physinorth Acquisition Corporation Inc.) (TSXV:...
Theratechnologies Announces that Data on the Mechanism of Effect of Tesamorelin in NAFLD will be Presented at The Liver Meeting® 2020
MONTREAL, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the...
Summit Announces Closing of Private Placement of $50 Million
Summit Therapeutics Inc.(“Summit” or the “Company”) Summit Announces Closing of Private Placement of $50 Million Cambridge, MA, November 6, 2020...
Tauriga Sciences, Inc. Experiencing Greater Market Acceptance for its Cannabis (CBD & CBG) Infused Chewing Gum Product Line
NOV 6 PR Complete Tauri-Gum™ Product Line (6 Flavors) The Recent Improvements to the U.S. Legal and Regulatory Landscape Have...